Vyome Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 3.35 M
as on 14-12-2024
- Company Age 14 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -66.00%
(FY 2022)
- Profit 47.98%
(FY 2022)
- Ebitda 61.70%
(FY 2022)
- Net Worth -22.22%
(FY 2022)
- Total Assets -22.13%
(FY 2022)
About Vyome Biosciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 3.35 M, as per Ministry of Corporate Affairs (MCA) records.
Shiladitya Sengupta, Rajeev Mantri, Ranjana Kumar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U33110GJ2010PTC099141
- Company No.
099141
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Aug 2010
- Date of AGM
06 Nov 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Vyome Biosciences Private Limited offer?
Vyome Biosciences Private Limited offers a wide range of products and services, including Medical Consultants & Clinics, Skin Treatment Solution, Cosmetics, Hair & Beauty Products, Hair Oil.
Who are the key members and board of directors at Vyome Biosciences?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Gupta  | Director | 29-Nov-2018 | Current |
Shiladitya Sengupta  | Director | 19-Aug-2010 | Current |
| Rajeev Mantri | Director | 30-Mar-2019 | Current |
| Ranjana Kumar | Director | 03-Nov-2010 | Current |
| Venkateswarlu Nelabhotla | Director | 30-Sep-2013 | Current |
Financial Performance and Corporate Structure Insights of Vyome Biosciences.
Vyome Biosciences Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 66% decrease. The company also saw a substantial improvement in profitability, with a 47.98% increase in profit. The company's net worth observed a substantial decline by a decrease of 22.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vyome Biosciences?
In 2022, Vyome Biosciences had a public holding of 54.72%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vyome Therapeutics LimitedActive 7 years 3 monthsShiladitya Sengupta, Ranjana Kumar and 1 more are mutual person
Medzara Healthtech Private LimitedActive 5 years 7 monthsVenkateswarlu Nelabhotla is a mutual person
Invictus Oncology Private LimitedActive 13 years 8 monthsShiladitya Sengupta and Rajeev Mantri are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Vyome Biosciences?
Vyome Biosciences has a workforce of 1 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vyome Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vyome Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
